DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Sehn LH, Herrera AF, Flowers CR. et al.
Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma.
J Clin Oncol 2020;
38 (02) 155-165
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.